
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Complete Medical Emergencies Interactive Quiz</title>
  <style>
    body { font-family: Georgia, serif; max-width: 900px; margin: auto; font-size: 18px; line-height: 1.6; padding: 40px; }
    select { font-size: 16px; }
    .section { display: none; }
    .section.active { display: block; }
    .next-btn, .prev-btn {
      position: fixed;
      bottom: 20px;
      right: 20px;
      padding: 10px 15px;
      font-size: 16px;
      cursor: pointer;
      background-color: #4CAF50;
      color: white;
      border: none;
      border-radius: 5px;
    }
    .prev-btn { right: 120px; background-color: #f44336; }
  </style>
</head>
<body>

<h1>Complete Medical Emergencies Quiz</h1>

<div id="quiz-container">

<div class="section">
  <h1>3.1 ADRENAL INSUFFICIENCY</h1>
  <p><br>3.1 <select><option>Select...</option><option>adrenal insufficiency</option><option>Option A</option><option>Option B</option><option>Option C</option></select></p><p>Standing Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. Maintain adequate mentation (following commands) or <select><option>Select...</option><option>MAP</option><option>Option A</option><option>Option B</option><option>Option C</option></select> > 65 mmHg, consider <select><option>Select...</option><option>fluid bolus</option><option>Option A</option><option>Option B</option><option>Option C</option></select> as needed.</p><p>3. <select><option>Select...</option><option>Vasopressor</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (Norepinephrine preferred) infusion to maintain adequate mentation (following commands) or MAP > 65 mmHg (see Protocol 3.16: Shock States).</p><p>4. If signs of adrenal crisis/insufficiency are present, administer “stress-dose” <select><option>Select...</option><option>Hydrocortisone</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 100 mg <select><option>Select...</option><option>IV</option><option>Option A</option><option>Option B</option><option>Option C</option></select>/<select><option>Select...</option><option>IO</option><option>Option A</option><option>Option B</option><option>Option C</option></select>/<select><option>Select...</option><option>IM</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (heavily preferred) OR <select><option>Select...</option><option>Methylprednisolone</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 125 mg IV/IO/IM.</p><p>+ IV steroids should be given to patients with known chronic adrenal insufficiency (also referred to as <select><option>Select...</option><option>Addison's Disease</option><option>Option A</option><option>Option B</option><option>Option C</option></select>) who have the following illnesses/injuries:</p><p>+ <select><option>Select...</option><option>Shock state</option><option>Option A</option><option>Option B</option><option>Option C</option></select>;</p><p>+ Fever with ill-appearance;</p><p>+ Multi-system <select><option>Select...</option><option>trauma</option><option>Option A</option><option>Option B</option><option>Option C</option></select>;</p><p>+ Drowning;</p><p>+ Environmental HYPER/<select><option>Select...</option><option>Hypothermia</option><option>Option A</option><option>Option B</option><option>Option C</option></select>;</p><p>+ Vomiting/Diarrhea with <select><option>Select...</option><option>dehydration</option><option>Option A</option><option>Option B</option><option>Option C</option></select>;</p><p>+ 2nd or 3rd Degree burns with > 5% BSA involvement;</p><p>+ <select><option>Select...</option><option>Hypoglycemia</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>Medical Control Options</p><p>1. Repeat doses of the above medications.<br></p>
</div><div class="section">
  <section>
    <h1>3.2 ALLERGIC REACTION/ANAPHYLAXIS</h1>
    <p>tanding Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.<br>2. Administer <select><option>Select...</option><option>oxygen</option><option>Option A</option><option>Option B</option><option>Option C</option></select> as needed to manage <select><option>Select...</option><option>hypoxia</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>3. Maintain adequate mentation (following commands) or systolic<br>blood pressure > 100 mmHg, consider <select><option>Select...</option><option>fluid bolus</option><option>Option A</option><option>Option B</option><option>Option C</option></select> as routine care<br>for <select><option>Select...</option><option>anaphylaxis</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>* In the setting of anaphylactic hypotension initiate Aggressive<br><select><option>Select...</option><option>IV Fluid resuscitation</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (1-2 L appropriate prehospitally).</p><p>4. For simple allergic reactions, consider <select><option>Select...</option><option>Diphenhydramine</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 25-50 mg<br>IV/IO/IM.<br>5. For severe distress, administer <select><option>Select...</option><option>Epinephrine</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 0.3 mg IM and consider<br>the medications listed below.<br>+ Second dose may be administered in 5 minutes, if necessary.</p><p>6. Albuterol 2.5 mg via nebulizer, repeated every 5 minutes up to 4<br>total doses for wheezing/respiratory distress.</p><p>7. Methylprednisolone 125 mg |V/IO/IM (heavily preferred) OR<br>Hydrocortisone 100 mg |V/|O/IM.</p><p>8. Vasopressor (Epinephrine preferred) infusion to maintain SBP ><br>100 mmHg (see Protocol 3.16: Shock States).</p><p>+ Note — When treating anaphylaxis with hypotension,<br>administering a second IM Epinephrine should indicate the need<br>to proactively assemble an Epinephrine infusion. The second IM<br>Epinephrine acts as a bridge to give you time to prepare that<br>infusion!</p><p>Medical Control Options</p><p>1. Additional doses of the above medications.</p>
  </section>
  <section>
    <h1>3.3 ALTERED MENTAL STATUS</h1>
    <p>tanding Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. Immediate assessment of the <select><option>Select...</option><option>primary survey</option><option>Option A</option><option>Option B</option><option>Option C</option></select> and stabilization of<br>life-threats.</p><p>Determine comprehensive <select><option>Select...</option><option>mental status</option><option>Option A</option><option>Option B</option><option>Option C</option></select> — <select><option>Select...</option><option>AVPU</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>Obtain point-of-care <select><option>Select...</option><option>blood glucose</option><option>Option A</option><option>Option B</option><option>Option C</option></select> level, and consider use of end-<br>tidal waveform <select><option>Select...</option><option>capnography</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>5. Attempt <select><option>Select...</option><option>neurologic assessment</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>6. Consider more intensive investigation of the scene and interview of<br>bystanders to obtain both <select><option>Select...</option><option>history</option><option>Option A</option><option>Option B</option><option>Option C</option></select> of the present illness and past<br>medical history.</p><p>7. Key cause considerations — stroke, seizure, infection, toxicity, trauma,<br>adrenal crisis, behavioral.</p><p>Medical Control Options</p><p>8. N/A.</p>
  </section>
</div><div class="section">
  <section>
    <h1>3.4 BEHAVIORAL EMERGENCIES</h1>
    <p>tanding Orders</p><p>1. Attempt <select><option>Select...</option><option>verbal de-escalation</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>2. Attempt to ascertain if the patient has capacity to make medical<br>decisions.</p><p>Maintain bystander and provider safety.</p><p>Consider use of <select><option>Select...</option><option>restraints</option><option>Option A</option><option>Option B</option><option>Option C</option></select>, if indicated for patient and/or provider<br>safety with assistance of <select><option>Select...</option><option>law enforcement</option><option>Option A</option><option>Option B</option><option>Option C</option></select> personnel.</p><p>Use least restrictive method possible;</p><p>Use only <select><option>Select...</option><option>soft restraints</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (if handcuffs are used, handcuffs<br>must be in front with key readily accessible);</p><p>Provide <select><option>Select...</option><option>padding</option><option>Option A</option><option>Option B</option><option>Option C</option></select> to restrained extremities and head, as<br>needed;</p><p>A minimum of 4 providers should be present for restraint of<br>an individual to maintain safety;</p><p>A patient should NEVER be transported in the prone position<br>or with equipment that forms a “sandwich” around a patient.</p><p>5. Consider administration of pharmacological agent if needed to<br>maintain patient and/or provider safety.</p><p>+ Haloperidol 5-10 mg |M ONLY<br>+ Should be paired with Midazolam 0.1 mg/kg;<br>+ Midazolam 0.1 mg/kg |V/!O/IM/IN to maximum dose of 6 mg;</p><p>+ Ketamine 4 mg/kg |M only, to maximum single dose of 400<br>mg.</p><p>Medical Control Options</p><p>1. Additional doses of the above medications.</p>
  </section>
  <section>
    <h1>3.5 BRONCHOSPASM/RESPIRATORY DISTRESS</h1>
    <p>tanding Orders</p><p>Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.<br>Administer <select><option>Select...</option><option>oxygen</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p><select><option>Select...</option><option>Albuterol</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 2.5 mg via nebulizer. <select><option>Select...</option><option>Ipratropium Bromide</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 0.5 mg may<br>be combined with Albuterol treatment. Additional Albuterol may be<br>administered as needed with or without additional Ipratropium<br>Bromide.</p><p>For severe distress, <select><option>Select...</option><option>Epinephrine</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 0.3 mg IM as a one-time dose.</p><p>In patients with a known history of asthma or COPD, consider<br><select><option>Select...</option><option>Methylprednisolone</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 125 mg |V/|0/IM (heavily preferred) or<br><select><option>Select...</option><option>Hydrocortisone</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 100 mg |V/|O/IM.</p><p>For moderate/severe distress due to asthma only, consider<br>Magnesium Sulfate 2-4 g over 20 minutes.</p><p>Consider the use of CPAP for signs of respiratory distress after<br>administration of the above.</p><p>+ Initiate at 5 cm H20O; titrate PEEP as needed;</p><p>+ Use with caution when SBP < 90 mmHg, decreased LOC and/<br>or active vomiting/airway hemorrhage.</p><p>Note — In the setting of suspected pneumonia — oxygen & CPAP are<br>the recommended prehospital treatments. Duoneb treatment(s) should<br>be withheld, unless the patient has a history of Asthma/COPD with<br>concurrent wheezes on auscultation.</p><p>Medical Control Options</p><p>1.</p><p>Additional doses of the above medications.</p>
  </section>
  <section>
    <h1>3.6 DIABETIC EMERGENCIES</h1>
    <p>tanding Orders</p><p>1. For <select><option>Select...</option><option>hypoglycemia</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (point-of-care blood glucose levels < 70 mg/dL in<br>adults & pediatrics, < 50 mg/dL in neonates) —</p><p>+ If the patient is alert and protecting their own airway/able to<br>swallow — consider <select><option>Select...</option><option>oral glucose</option><option>Option A</option><option>Option B</option><option>Option C</option></select> or sugary liquids (i.e. orange<br>juice). Once the patient’s BGL returns to normal they should<br>be advised to eat a meal with complex carbohydrates.</p><p>+ If the patient is not alert or cannot protect their own airway —<br>+ Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>+ Administer <select><option>Select...</option><option>Dextrose</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 10% 12.5-25 g IVP (may also give<br>Dextrose 50%).</p><p>+ If unable to obtain IV access administer Glucagon 1 mg<br>IM</p><p>2. For hyperglycemia (point-of-care blood glucose levels > 250 mg/dL)<br>+ Obtain vascular access.<br>+ Administer appropriate IV fluid bolus.</p><p>+ The hyperglycemic state is rarely, if ever, the primary issue. This<br>necessitates investigation of possible metabolic stressors such<br>as stroke, myocardial infarction, infection, gastrointestinal<br>hemorrhage, traumatic injury, burn, etc.</p><p>Medical Control Options</p><p>1. Additional doses of the above medications.</p>
  </section>
  <section>
    <h1>3.7 HYPERKALEMIA</h1>
    <p>tanding Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. Should be suspected in patients at high risk for developing<br><select><option>Select...</option><option>hyperkalemia</option><option>Option A</option><option>Option B</option><option>Option C</option></select> —</p><p>* <select><option>Select...</option><option>Chronic Kidney Disease</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (CKD) and <select><option>Select...</option><option>End-Stage Renal Disease</option><option>Option A</option><option>Option B</option><option>Option C</option></select><br>(ESRD);</p><p>* Those with <select><option>Select...</option><option>adrenal insufficiency</option><option>Option A</option><option>Option B</option><option>Option C</option></select>;</p><p>* Those at risk of developing <select><option>Select...</option><option>Acute Renal Failure</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (severe<br>dehydration, shock, nephrotoxicity, obstruction, crush injury,<br>compartment syndrome, and rhabdomyolysis).</p><p>3. If ahigh risk patient develops signs of hyperkalemia on 12-lead<br>ECG they are at risk of entering sudden cardiac arrest. See table on<br>next page.</p><p>4. Administer Calcium Chloride 1 gram lV over at least 5 minutes.</p><p>5. Administer nebulized Albuterol 2.5 mg and repeat as needed.</p><p>Medical Control Options</p><p>1... Contact medical control if the ECG changes have not resolved to<br>obtain orders for additional doses of Calcium Chloride.</p>
  </section>
</div><div class="section">
  <section>
    <h1>3.8 HYPERTHERMIA (ENVIRONMENTAL)</h1>
    <p>(ENVIRONMENTAL)</p><p>Standing Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. If you have high suspicion for <select><option>Select...</option><option>heat stroke</option><option>Option A</option><option>Option B</option><option>Option C</option></select>, take immediate steps to<br>remove the patient from a hot environment.</p><p>3. For suspected heat cramps or <select><option>Select...</option><option>dehydration</option><option>Option A</option><option>Option B</option><option>Option C</option></select>, initiate <select><option>Select...</option><option>passive cooling</option><option>Option A</option><option>Option B</option><option>Option C</option></select><br>techniques — move to a cool area, utilize convective cooling via<br>fans and air conditioning, hydrate with <select><option>Select...</option><option>IV fluids</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>4. For suspected heat exhaustion, heat stroke, or exercise-induced<br><select><option>Select...</option><option>hyponatremia</option><option>Option A</option><option>Option B</option><option>Option C</option></select> initiate both passive and <select><option>Select...</option><option>active cooling</option><option>Option A</option><option>Option B</option><option>Option C</option></select> techniques —<br>apply ice packs to the groin and axillae, initiate IV fluids, and<br>utilization of water immersion or wetting the patient with aggressive<br>fanning.</p><p>5. For heat stroke, anticipate the possibility of rapidly progressing<br>shock, which can occur even after cooling the patient below 102 °F.</p><p>Medical Control Options</p><p>1. For suspected heat cramps or dehydration during medical stand-by<br>(i.e. tent at local 5K run) and with medical control approval consider<br>having the patient drink sodium-containing cool liquids.</p><p>2. If the cause of the hyperthermia is exertional and thermometry is<br>available on-site, consider completing these cooling procedures in<br>place for approximately 20 minutes with goal temperature of<br>102.2 °F (39°C), unless additional concerns indicate immediate<br>need for hospital care.</p>
  </section>
  <section>
    <h1>3.9 HYPOTHERMIA (ENVIRONMENTAL)</h1>
    <p>(ENVIRONMENTAL)</p><p>Standing Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. Always treat <select><option>Select...</option><option>systemic hypothermia</option><option>Option A</option><option>Option B</option><option>Option C</option></select> prior to addressing suspected<br><select><option>Select...</option><option>frostbite</option><option>Option A</option><option>Option B</option><option>Option C</option></select>.</p><p>3. Avoid rough movement and prevent further heat loss —<br>+ Insulate from the ground and shield from wind/water;<br>+ Move to a warm environment as soon as practical;<br>+ Remove and wet clothing or constrictive jewelry;<br>* Cover with warm blankets.</p><p>4. If patient’s core body temperature is below 95 °F (35°C) consider<br><select><option>Select...</option><option>active rewarming</option><option>Option A</option><option>Option B</option><option>Option C</option></select> with warmed (39°C) IV fluids.</p><p>5. Resuscitation of a hypothermic patient should not be ceased or<br>abandoned until the patient has remained in arrest with a normal<br>core body temperature.</p><p>Medical Control Options</p><p>1. If the patient fails to respond to the initial defibrillation attempt or<br>initial drug therapy, defer subsequent defibrillation attempts or<br>additional boluses of medication until the core temperature rises<br>above 86°F (30°C).</p>
  </section>
</div><div class="section">
  <section>
    <h1>3.10 NERVE AGENT/ORGANOPHOSPHATE POISONING</h1>
    <p>tanding Orders</p><p>1. Ensure the patient has been appropriately decontaminated before<br>they are move to the cold zone.</p><p>2. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>3. Assess for signs of <select><option>Select...</option><option>cholinergic toxicity</option><option>Option A</option><option>Option B</option><option>Option C</option></select> — <select><option>Select...</option><option>SLUDGEM</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (Salivation,<br>Lacrimation, Urination, Dedication, Gastric distress, Emesis, Muscle<br>twitching/Miosis) or Killer B’s (Bradycardia, Bronchorrhea,<br>Bronchospasm).</p><p>4. <select><option>Select...</option><option>Antidotal therapy</option><option>Option A</option><option>Option B</option><option>Option C</option></select> should be initiated as soon as symptoms appear<br>but not prophylactically.</p><p>5. Antidote <select><option>Select...</option><option>auto-injectors</option><option>Option A</option><option>Option B</option><option>Option C</option></select> — 1-3 DuoDote kits — should be<br>administered IM based on the presenting signs/symptoms — see<br>chart on next page.</p><p>6. If symptoms persist after administration of three (3) DuoDote kits<br>consider administration of additional doses IV —</p><p>* Atropine 2 mg |\/lO; repeat every 5 minutes until secretions<br>clear;</p><p>* Pralidoxime 1-2 gram(s) |V/IO over 30-60 minutes</p><p>* Diazepam 10 mg IM via auto-injector OR Midazolam 6 mg IM<br>every 10 minutes as need, OR Midazolam 2 mg |V/IO/IN every<br>5 minutes</p><p>Medical Control Options</p><p>1. Additional doses of the above medications.</p><p>Severity</p><p>Cholinergic Toxicity Signs</p><p>& Symptoms</p><p>Adult Standing Orders<br>(Patient weight > 55 kg)</p><p>* Runny Nose</p><p>Administer one(1)</p><p>* Cough DuoDote kit IV.<br>* Miosis (pupillary constriction)<br>* Eye pain — OR—<br>Mild * Lacrimation (excessive flow of .<br>tears) + Atropine 2 mg |M-only.<br>+ And either Pralidoxime<br>600 mg IM, OR<br>Pralidoxime 1 gram IV.<br>All of the above and possibly to. | * Administer two(2)<br>include — DuoDote kits IM.<br>* Sweating (could be localized<br>with dermal exposure) — OR—<br>* Twitching .</p><p>Moderate |* Nausea . Atropine 4 mg iM-only.<br>* Abdominal cramping + And either Pralidoxime<br>* Weakness 600-1200 mg |M, OR<br>* Disruption to visual acuity Pralidoxime 1 gram IV.<br>* Shortness of breath/</p><p>wheezing<br>All of the above and possibly to. |» Administer three(3)<br>include — DuoDote kits IV.<br>+ Vomiting<br>* Diarrhea — OR—<br>+ Dysphagia (drooling or .<br>copious respiratory . Atropine 6 mg IM-only.<br>Severe secretions) + And either Pralidoxime<br>* Seizures 1200-1800 mg |M, OR<br>* Decreased LOC Pralidoxime 1 gram IV.<br>+ Apnea + Diazepam 10 mg IM via<br>auto-injector, OR<br>Midazolam 6-10 mg |\V/</p><p>IO/IM.</p>
  </section>
  <section>
    <h1>3.11 OBSTETRICAL EMERGENCIES</h1>
    <p>tanding Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. For <select><option>Select...</option><option>imminent birth</option><option>Option A</option><option>Option B</option><option>Option C</option></select> expose as indicated to assess for hemorrhage/<br>discharge, crowning, <select><option>Select...</option><option>prolapsed cord</option><option>Option A</option><option>Option B</option><option>Option C</option></select>, breech or limb presentation.</p><p>3. <select><option>Select...</option><option>perineal inspection</option><option>Option A</option><option>Option B</option><option>Option C</option></select> —<br>* Infant's head bulges the perineum, or crowning is present;</p><p>+ |f prolapsed cord is present, elevate the fetal head off the<br>cord using 2-3 fingers, place patient in Trendelenberg<br>position, and rapidly transport to the nearest capable facility;</p><p>4. Support the perineum with a sterile towel and place the other hand<br>over the occiput to promote fetal head extension;</p><p>5. Slowly deliver the head —</p><p>* Check for nuchal cord — If present, slip finger between<br>neonate's neck and cord & attempt to reduce cord by pulling<br>it over neonate's head;</p><p>* If unable to reduce cord, clamp and cut cord if neonate's<br>face can be cleared from perineum with immediate suction;</p><p>6. Deliver anterior shoulder —</p><p>* Position hands on either side of the head and exert a gentle<br>downward force;</p><p>7. Deliver posterior shoulder —</p><p>* Maintain position of hands and apply a small amount of<br>upward traction;</p><p>8. Delivery of the body —<br>* Controlled expulsion helps to prevent perineal lacerations;</p><p>* Hold the infant securely;</p><p>* Position in a manner that facilitates the flow of blood from<br>the placenta to the neonate;</p><p>* Dry, warm, & stimulate the neonate;</p><p>9. Only if neonate exhibits respiratory depression, regardless of the<br>presence of meconium-stained amniotic fluid, suction the<br>oropharynx and then the nares (routine suctioning is not advised);</p><p>10. Clamp then cut the umbilical cord with sterile scissors or a scalpel<br>leaving at least 2-4 cm of cord attached to the neonate;</p><p>11. If uncomplicated delivery with clear airway and good respiratory<br>support, mother may hold child immediately (skin to skin)</p><p>* If mother or infant is unstable, pass infant to resuscitation<br>team, or move to the resuscitation area if there are limited<br>resources available;</p><p>* See newborn resuscitation for treatment.</p><p>1. For Eclamptic Seizures administer —</p><p>* Midazolam 0.1 mg/kg |V/|O/IM to maximum of 8 mg, OR<br>Midazolam 0.2 mg/kg |N when IV access is unavailable to<br>maximum of 10 mg.</p><p>+ Magnesium Sulfate 2-4 grams |V/|O over 5 minutes.</p><p>2. Special Consideration during cardiac arrest — if fundal height is at<br>or above the umbilicus, manually displace the gravid uterus to the<br>left to enhance venous return (if additional resources enable you to<br>do so).</p><p>3. For non-compressible postpartum hemorrhage that cannot be<br>controlled by fundal massage, skin-to-skin contact, or nursing<br>administer Tranexamic Acid 1 gram diluted in 100 cc over 10<br>minutes.</p><p>Medical Control Options</p><p>1. Additional doses of the above medications.</p>
  </section>
</div><div class="section">
  <section>
    <h1>3.12 PAIN/NAUSEA MANAGEMENT</h1>
    <p>tanding Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. For nausea administer <select><option>Select...</option><option>Ondansetron</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 4 mg |V/IO/IM/IN/PO.<br>3. For pain administer either —</p><p><select><option>Select...</option><option>Fentanyl</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 1 mcg/kg |V/lO/IM/IN, OR;</p><p><select><option>Select...</option><option>Ketamine</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 0.15 mg/kg |V/IO slow push, may repeat dose one<br>time in 20 minutes, OR;</p><p><select><option>Select...</option><option>Morphine</option><option>Option A</option><option>Option B</option><option>Option C</option></select> Sulfate 0.1 mg/kg |V/IO/IM to maximum dose of 10<br>mg, OR;</p><p><select><option>Select...</option><option>Ketorolac</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 15 mg lV, or 30 mg IM, OR;</p><p><select><option>Select...</option><option>Acetaminophen</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 15 mg/kg PO or IV to maximum dose of 1g.</p><p>Medical Control Options</p><p>1. Additional doses of the above medications.</p>
  </section>
  <section>
    <h1>3.13 POISONING/SUBSTANCE ABUSE</h1>
    <p>tanding Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.<br>2. Perform 12-Lead ECG as indicated.</p><p>3. For suspected <select><option>Select...</option><option>Opiate Toxicity</option><option>Option A</option><option>Option B</option><option>Option C</option></select>, administer <select><option>Select...</option><option>Naloxone</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 0.4-2 mg |V/lO/<br>IM/IN to maximum total dose of 10 mg.</p><p>4. For other suspected toxicities —<br>* Contact <select><option>Select...</option><option>Poison Control</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (800.222.1222)</p><p>* Contact Medical Control</p><p>Medical Control Options</p><p>1. For Calcium-Channel Blocker or B-Blocker Toxicity —</p><p>* <select><option>Select...</option><option>Calcium Chloride</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 1g |V/|O push over at least 5 minutes.</p><p>* <select><option>Select...</option><option>Glucagon</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 5-10 mg |V over 5 minutes repeated until<br>bradycardia is resolved.<br>2. For Tricyclic Antidepressant Toxicity, Cardiotoxicity resulting in a<br>widened QRS/Sodium-Channel Blocker Toxicity, or Salicylate<br>Toxicity with signs of acidosis or altered mental status —</p><p>* Sodium Bicarbonate 1 mEq/kg |V/|O.</p><p>3. For Organophosphate Toxicity —</p><p>* Refer to Protocol 3.10: Nerve Agent/Organophosphate<br>Poisoning.<br>4. For Cyanide Toxicity —</p><p>* Hydroxocobalamin 5 g |V/IO over 15 min diluted in 250 mL of<br>IV fluid.</p><p>5. Additional doses of the above medications.</p>
  </section>
  <section>
    <h1>3.14 SEIZURES</h1>
    <p>tanding Orders</p><p>1. Attempt to obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. Immediate assessment of the <select><option>Select...</option><option>primary survey</option><option>Option A</option><option>Option B</option><option>Option C</option></select> and stabilization of<br>life-threats.</p><p>* Consider use of nasal cannula for <select><option>Select...</option><option>oxygen therapy</option><option>Option A</option><option>Option B</option><option>Option C</option></select> due to<br>increased aspiration risk.</p><p>3. Cardiac monitor and if feasible perform 12-lead ECG.<br>* Manage dysrhythmias per protocol.</p><p>4. If the patient is in <select><option>Select...</option><option>Status Epilepticus</option><option>Option A</option><option>Option B</option><option>Option C</option></select> or a life-threat has developed<br>as a complication from the seizure administer —</p><p>* <select><option>Select...</option><option>Midazolam</option><option>Option A</option><option>Option B</option><option>Option C</option></select> 0.1 mg/kg |V/|O/IM to maximum of 8 mg, OR<br>Midazolam 0.2 mg/kg |N when IV access is unavailable to<br>maximum of 10 mg.</p><p>5. For Eclamptic Seizures administer —<br>* Magnesium Sulfate 2-4 grams |V/lO over 5 minutes.</p><p>* Note that eclamptic seizures can occur up to several weeks<br>postpartum.</p><p>6. Attempt neurologic assessment as soon as practical.</p><p>Medical Control Options</p><p>1. Additional doses of the above medications.</p>
  </section>
  <section>
    <h1>3.15 SEPSIS</h1>
    <p>tanding Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. Identify possible sepsis — patient must have a suspected source of<br>infection and meet at least two(2) of the following Systemic<br>Inflammatory Response Syndrome (SIRS) Criteria —</p><p>Temperature > 100.4 °F, OR Temperature < 96.8 °F;</p><p>Heart rate > 90 bom;</p><p>Respiratory rate > 22 bpm;</p><p>Systolic blood pressure < 90 mmHg, OR Mean arterial blood<br>pressure (MAP) < 65 mmHg;</p><p>New onset altered or worsening mental status;<br>* <select><option>Select...</option><option>ETCO2</option><option>Option A</option><option>Option B</option><option>Option C</option></select> < 25 mmHg</p><p>3. Obtain large-bore IV access and administer aggressive fluid<br>resuscitation (1-2 L appropriate prehospitally) starting with a 500<br>cc IV fluid bolus — repeat boluses may be required — targeting<br>adequate mentation (following commands) and/or a systolic blood<br>pressure > 100 mmHg.</p><p>4. If patient has limited response to IV fluid, OR presents with a MAP <<br>65 mmug with signs of poor perfusion initiate a vasopressor<br>(Norepinephrine preferred) (refer to Protocol</p>
  </section>
  <section>
    <h1>3.16 SHOCK STATES</h1>
    <p>tanding Orders</p><p>1. Attempt to obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. Treatment for shock is entirely dependent on the cause. Ensure you<br>adequately assess the patient’s presentation to determine the best<br>course of action. See chart on following pages.</p><p>3. For Distributive and (Non-Hemorrhagic) Hypovolemic causes of<br>shock —</p><p>+ Administer aggressive <select><option>Select...</option><option>fluid resuscitation</option><option>Option A</option><option>Option B</option><option>Option C</option></select> (1-2 L appropriate<br>prehospitally) starting with a 500 cc IV fluid bolus — repeat<br>boluses may be required.</p><p>* If patient has limited response to IV fluid, OR; presents with a<br>MAP < 65 mmHg with signs of poor perfusion initiate a<br>vasopressor infusion —</p><p>* In neurogenic shock the target MAP is > 80 mmHg.</p><p>* Norepinephrine 0.1-0.5 mcg/kg/min |V/|O (must be<br>given through an IV pump prehospitally) OR;</p><p>* Epinephrine 2-10 mcg/min |V/lO (2 mg of 1:1000 mixed</p><p>into 250 mL of normal saline results in 15 gtts/min = 2<br>meg/min), OR;</p><p>* Dopamine 2-20 mg/kg/min IV/IO (starting at 10 mcg/<br>kg/min to achieve a-effects).</p><p>* Note — For resuscitation of shock Norepinephrine is the<br>preferred vasopressor of choice. The only exceptions to this are<br>when treating Anaphylactic Shock, or correcting Cardiogenic<br>Shock in a patient who is bradycardic, at which point<br>Epinephrine is the preferred vasopressor of choice.</p><p>For suspected adrenal crisis refer to Protocol</p>
  </section>
  <section>
    <h1>3.17 STROKE (CVA)</h1>
    <p>(CVA)</p><p>Standing Orders</p><p>1. Obtain <select><option>Select...</option><option>vascular access</option><option>Option A</option><option>Option B</option><option>Option C</option></select>. Routine Patient Care.</p><p>2. As soon as stroke is suspected perform a rapid FAST-ED Stroke<br>Exam to determine if rapid extrication and transport is indicated.</p><p>3. Prior to leaving the scene it is crucial to determine the patient’s<br><select><option>Select...</option><option>neurologic baseline</option><option>Option A</option><option>Option B</option><option>Option C</option></select>, and more importantly what the precise time is<br>that they were seen at that baseline, known as a Last Known<br>Normal.</p><p>4. Transport the patient as rapidly as possible with the head of the<br>stretcher at 30° and notify the hospital of incoming Stroke Alert<br>prior to arrival in an attempt to reduce the “door to needle” time<br>(Tissue Plasminogen Activator or “TPA’).</p><p>5. Continue to perform full ALS assessment including a<br>comprehensive neurologic exam and obtaining key history/<br>diagnostics such as —</p><p>* PMH including whether the patient is prescribed anticoagulant<br>or anti-platelet medications;</p><p>* Point-of-care blood glucose level;<br>* Temperature, 12-lead ECG, and serial vital signs;</p><p>6. Ensure you are performing serial stroke exams to assess the<br>progression or improvement/resolution of any deficits.</p><p>Medical Control Options</p><p>1. If there is strong suspicion for hemorrhagic stroke medical control<br>can order to bypass a local stroke center and transport to a<br>comprehensive stroke center with additional capabilities. This<br>should only be utilized when the patient is stable enough to be<br>transported to a further destination.</p><p>FAST-ED STROKE SCALE</p><p>Facial Palsy</p><p>Normal or minor paralysis</p><p>Partial or complete paralysis</p><p>No drift</p><p>Drift or some effort against gravity</p><p>No effort against gravity or no movement</p><p>Speech Changes</p><p>Absent</p><p>Mild to moderate</p><p>Severe, global aphasia or mute</p><p>Eye Deviation</p><p>Absent</p><p>Partial</p><p>Forced deviation</p><p>Denial/Neglect</p><p>Absent</p><p>Extinction to bilateral simultaneous stimuli in only 1<br>sensory modality</p><p>Does not recognize their own hand or orients to<br>only one side of the body</p><p><br>PEDIATRIC<br>EMERGENCIES</p><p>ak</p>
  </section>
</div>
</div>

<button class="prev-btn" onclick="changeSection(-1)">Previous</button>
<button class="next-btn" onclick="changeSection(1)">Next</button>

<script>
  let currentSection = 0;
  const sections = document.querySelectorAll('.section');
  sections[currentSection].classList.add('active');

  function changeSection(step) {
    sections[currentSection].classList.remove('active');
    currentSection += step;
    if (currentSection >= sections.length) currentSection = 0;
    if (currentSection < 0) currentSection = sections.length - 1;
    sections[currentSection].classList.add('active');
    window.scrollTo(0, 0);
  }
</script>

</body>
</html>
